Transformed ®broblast from p53 null/null mice were tested for their sensitivity to intercellular induction of apoptosis by TGF-b-treated nontransformed cells. They were found to be as sensitive as p53-positive transformed cells. Based on morphological criteria, detection of chromatin condensation and DNA strand breaks, death of p53-negative transformed cells was due to apoptosis. p53-negative nontransformed cells were as ecient in the induction of apoptosis in transformed cells as p53-positive nontransformed cells. These data show that intercellular induction of apoptosis in transformed cells does not depend on functional p53. Therefore it may be assumed that mutations of p53 or modulation of its concentration are without relevance for this particular aspect of control of oncogenesis.
Introduction p53 was initially de®ned as a classical tumor suppressor gene that interfered with the transformation event (Finlay et al., 1989; Eliyahu et al., 1989; Michalovitz et al., 1990) . It was then recognized that p53 plays a central role in cell cycle control and induction of apoptosis (for review see Lieberman et al., 1995; GoÈ tz and Montenarh, 1995) . p53-dependent gene expression after DNA damage is substantial for the maintenance of integrity of the cellular genome. Following DNA damage, p53, the`guardian of the genome' (Lane, 1992) , can either cause cell cycle arrest, which is followed by repair activities, or apoptosis of the aected cell (Nelson and Kastan, 1994; El-Eiry et al., 1994; Lowe et al., 1993b; Yonish-Rouach et al., 1993) which neutralizes the potential hazard of mutations.
Several lines of evidence connect missing p53 function and tumor formation and development. (1) Mutations in the p53 gene are frequently found in human tumors (Hollstein et al., 1991; Greenblatt et al., 1994) . (2) p53 null/null mice show a high rate of spontaneous tumor formation, pointing to the tumor protective function of p53 (Donehower et al., 1992) . (3) Reintroduction of wild type p53 in tumor cells causes growth arrest and/or apoptosis (Mercer et al., 1990; Baker et al., 1990; Diller et al., 1990; Radinsky et al., 1994; Ramqvist et al., 1993; Symonds et al., 1994; Yonish-Rouach et al., 1991) . (4) The E6 proteins of tumorigenic human papilloma viruses HPV16 and HPV18 speci®cally bind to p53 and lead to its inactivation (Werness et al., 1990; Havre et al., 1995) . As a result, the p53-induced response after DNA damage is abolished (Gu et al., 1994) . This mechanism explains the increased rate of mutagenesis in HPVinfected cells (Havre et al., 1995) which may be one of the driving forces in HPV-associated carcinogenesis. (5) Recent ®ndings indicate that loss of p53 function in growing tumors selects for cells that are resistant to hypoxia-mediated apoptosis and thus can survive in and expand from the hypoxic situation of a growing tumor tissue (Graeber et al., 1996; Kinzler and Vogelstein, 1996) . Finally it is important to note that even the cytotoxicity of anticancer agents is dependent on functional p53 (Lowe et al., 1993a) .
Besides DNA damage, an increasing number of dierent stimuli have been recognized to induce p53-mediated apoptosis, such as growth factor deprivation (Gottlieb et al., 1994; Yonish-Rouach et al., 1991) , oncogene activation (Hermeking and Eick, 1994 ) and viral infection (Lowe and Ruley, 1993; Debbas and White, 1993) . This points to a central role of p53 in the response to dierent signi®cant biological stimuli and potential hazards. Induction of bax seems to represent a central step in the mechanism of apoptosis induction by p53 (Myashita and Reed, 1995) . Bcl-2, a negative regulator of apoptosis, which is related to the apoptosis inhibitor ced 9 gene of Caenorhabditis elegans (Reed, 1994) , can interfere with p53-induced apoptosis (Rao et al., 1992) . p53, in turn, is negatively acting on the expression of bcl-2 (Miyashita et al., 1994) .
However, many of the stimuli that induce p53-mediated apoptosis also act on p53-independent apoptosis induction systems existing in parallel (Lieberman et al., 1995; Clarke et al., 1993) . For example, adenovirus can induce p53-dependent (Lowe and Ruley, 1993; Debbas and White, 1993) as well as -independent pathways (Subramanian et al., 1995) . The same ®nding has been substantiated for DNA damage-induced apoptosis (Strasser et al., 1994) . p53-dependent and -independent apoptosis is acting during mouse lens development (Pan and Griep, 1995) . The inhibition of p53-dependent and -independent apoptosis inducing systems by Bcl-2 (Strasser et al., 1994; Sabbatini et al., 1995; Subramanian et al., 1995) may either indicate biochemical relationships between the two systems or their conversion into a ®nal common pathway.
We have recently described a novel system of intercellular induction of apoptosis, which has potential implications for the control of oncogenesis (for review see Bauer, 1995; 1996) . In this system, TGF-b triggers untransformed ®broblasts to speci®cally induce apoptosis in transformed cells (JuÈ rgensmeier et al., 1994; Bauer, 1996) . A large number of transformed cell lines derived from p53-positive ®broblast cell lines have been shown to be sensitive for intercellular induction of apoptosis (JuÈ rgensmeier et al., 1994; Wehrle et al., 1994; Beck et al., 1997; Descalzo et al., 1997; Panse et al., 1997) . Reactive oxygen species are involved in the TGF-b-induced signal chain in nontransformed cells and during induction of apoptosis in transformed cells (Schaefer et al., 1995; Langer et al., 1996) . Sensitivity of transformed cells to induction of apoptosis is independent of the principle that originally caused their transformation (Bauer, 1996) . The strong link between the transformed phenotype and sensitivity to intercellular induction of apoptosis was further substantiated by the ®nding that revertants from apoptosis-sensitive transformed cells regularly lost their sensitivity (Beck et al. manuscript in preparation) . Intercellular induction of apoptosis has therefore been postulated to represent a potent control step in oncogenesis (Bauer, 1995 (Bauer, , 1996 . If it acts in vivo as eciently as it does in vitro, tumor development should depend on acquisition of resistance against it. Two genetic systems have already been found to interfere with intercellular induction of apoptosis: Bcl-2 (JuÈ rgensmeier and and BPV (Melchinger et al., 1996) . Both represent ecient protectors of transformed cells and thus may be crucial for the prevention of killing of transformed cells by their cellular environment. To be eective, protective genes must be active prior to the transformation event. Activation of bcl-2 in preneoplastic lesions or persistent papilloma virus infection may therefore be the basis for ecient protection of transformed cells.
As p53 plays a central role for induction of apoptosis and control of oncogenesis, it was important to ®nd out whether intercellular induction of apoptosis is dependent on functional p53. If this was the case, inactivation of p53 might represent another powerful means for transformed cells to escape intercellular induction of apoptosis. In this paper we use a direct approach by testing p53 null/null transformed fibroblasts for sensitivity for intercellular induction of apoptosis and p53 null/null untransformed cells for their potential to induce intercellular apoptosis after stimulation with TGF-b.
Results
Cultures of nonimmortalized ®broblasts of a p53 null mouse were screened for spontaenous foci. A prominent focus was isolated, cultured and seeded in soft agar. Several soft agar colonies were isolated and further cultivated. These cell clones derived from the focus were immortalized and stably maintained the transformed phenotype, characterized by focus formation in monolayer culture and colony formation in soft agar (data not shown). In order to ensure their p53-negative status and to test the p53-positive reference cells for functional p53, cells were treated with mitomycin C and tested for nuclear accumulation of p53 and subsequent induction of apoptosis (Fritsche et al., 1993) . As can be seen in Table 1 , mitomycin C treatment caused typical nuclear p53 accumulation 16 h after addition of the DNA-damaging agent, followed by rapid induction of apoptosis in p53-positive cells, con®rming that they possess a functional p53 with the potential to induce a fast response to DNA damage. p53-negativity of p53 null/null cell lines was con®rmed by the absence of detectable immunouorescence stain. They showed a delayed p53-independent apoptotic response.
To test the p53-de®cient transformed clones for sensitivity to induction of apoptosis by neighboring nontransformed cells, clonal populations of two p53-negative transformed cell lines and a MCA-transformed p53-positive reference cell line were treated with or without TGF-b in the absence or presence of an excess of nontransformed mouse ®broblasts (C3H 10 T1/2) ( Figure 1b ). To test for the apoptosis-inducing function of p53-negative nontransformed cells, clones of the p53-positive transformed line MCA 18 C115 and of two p53-negative transformed cells were cocultured with an excess of p53-negative nontransformed ®broblasts ( Figure 1a ). After 5 days, speci®c damage of transformed cell clones was monitored. As can be seen in Figure 1 , coculture of transformed cells with nontransformed cells in the presence of TGF-b caused signi®cant induction of cell death of transformed cells, which was enhanced by exogenous TGF-b. p53-negative transformed cells were as sensitive for induction of apoptosis as their p53-positive counterpart. p53-negative nontransformed cells induced apoptosis in p53-negative and -positive transformed cells as eciently as p53-positive nontransformed cells. Therefore, the p53 status seems to be irrelevant both for the apoptosis-inducing potential of nontransformed cells and the sensitivity of transformed cells. The potential for intercellular induction of apoptosis was not unique for nontransformed C3H 10 T1/2 cells or the p53-negative parental cell line, but was veri®ed for immortalized rat ®broblasts and nonimmortalized human ®broblasts as well ( Table 2 ). The clonal analysis of the nontransformed cells performed in this experiment ensured that dierent nontransformed cell lines possess the potential to induce apoptosis in p53-negative transformed cells. In the presence of TGF-b, practically all of the subclones within the population exhibited apoptosis-inducing activity. The potential for intercellular induction of apoptosis in p53-negative transformed cells therefore seems to be a general feature of nontransformed ®broblasts. Cells were treated with 10 mg/ml mitomycin C or remained untreated. After 16 h nuclear accumulation of p53 was determined by immuno¯uorescence, using the monoclonal antibody 411 directed against p53, biotinylated goat anti-mouse IgG and FITC-labelled streptavidine. ++indicates that more than 90% of the cells showed a nuclear p53 signal. The percentage of apoptotic cells was determined after 26 and 50 h p53 and intercellular induction of apoptosis ML Hipp and G Bauer
To verify the nature of cell death as being apoptosis, the transformed p53-positive reference clone (MCA18 C115) and the p53-negative transformed clones were cultured both in the absence and presence of excess nontransformed cells and increasing concentrations of TGF-b. At the indicated time points, parallel cultures were ®xed and chromatin condensation within the transformed cell clones was monitored. Figure 2 shows the result for the reference clone and one representative p53-negative transformed cell line. Treatment of either p53-negative or -positive transformed cells with TGF-b alone did not induce measurable chromatin condensation. In the presence of nontransformed cells, a kinetic increase of apoptotic cells was observed both for p53-positive and negative cell lines. The degree of induction of apoptosis was dependent on the concentration of TGF-b added, but there was also a substantial degree of apoptosis in the assays without exogenously added TGF-b. This`basal degree of elimination', which is due to the action of TGF-b derived from transformed cells themselves (Hackenjos et al., 1996) was especially prominent for the p53-positive reference cell line.
To ensure that chromatin condensation as measured in the previous experiments indeed re¯ected apoptosis, desintegrity of the chromosomal DNA, another speci®c sign of apoptosis, was determined in parallel. Cocultures of p53-negative or p53-positive transformed cells with nontransformed cells, as well as pure cultures of nontransformed cells were cultivated in the presence of TGF-b. Cultures were ®xed and stained both in the TUNEL reaction, using terminal transferase and¯uoresceine-labeled dUTP (a reaction that speci®cally recognizes DNA strand breaks which are typical for apoptosis). After the TUNEL reaction, cells were stained with bis-benzimidine to detect chromatin condensation. As can be seen in Figure 3 , chromatin condensation and positive TUNEL reaction correlated very well in cocultures of p53-positive or -negative transformed cells with nontransformed cells. Cells showing intact chromatin did not stain in the TUNEL reaction. This ®nding con®rms that chromatin condensation as measured in Figure 2 was indeed due to apoptosis.
Irradiation has recently been shown to block the apoptosis-inducing activity of nontransformed cells (Bassler et al., 1997) . To ensure that apoptosis was induced in p53-negative and -positive transformed cells through the activity of nontransformed cells, p53-negative transformed cell lines and a p53-positive transformed reference cell line were grown as clones and then an excess of irradiated or non-irradiated nontransformed cells were added. TGF-b was added or not and induction of apoptosis was determined after 5 days. Untreated nontransformed cells induced apoptosis in transformed cells, independent of their p53 status. Similar to the experiment shown in Figure 2 , induction of apoptosis was more prominent in the presence of exogenously added TGF-b. In contrast, nontransformed cells blocked in their ability to induce apoptosis by gamma irradiation, only induced apoptosis in a minor population of the most sensitive clones (data not shown). Exogenous TGF-b did not increase the marginal induction of apoptosis observed. These data verify the role of nontransformed cells for intercellular induction of apoptosis in p53-negative transformed ®broblasts. C3H 10 T1/2 mouse ®broblasts, human nonimmortalized Alpha-1 ®broblasts or rat 208 F ®broblasts were sparsely seeded in the presence of 15% conditioned medium (cell-free medium from a con¯uent cell culture). After the clones had grown to a size of 50 ± 100 cells per clone, 60 000 transformed p53-negative ®broblasts (p53/02 were added. TGF-beta was added at a ®nal concentration of 1 ng/ml. After 4 days the percentage of clones exhibiting substantial apoptosis induction in overlaying transformed cells (more than 50% of transformed cells being apoptotic) was determined using phase contrast microscopy (Picht et al., 1994) . Though intercellular induction of apoptosis does not require cell-to-cell contact between transformed and nontransformed cells, apoptosis induction is ®rst seen above the nontransformed cell clones due to the eect of the close vicinity of both cell types. After 4 days, transformed cells between the nontransformed clones become apoptotic as well, whereas the nontransformed cells (characterised by their morphology) remain intact. Parallel controls ensured that 1 ng/ml TGF-b had no direct eect on transformed cells
Discussion
Our data show that intercellular induction of transformed cells by TGF-b-treated nontransformed cells does not require functional p53. Transformed ®broblasts from a p53-null/null mouse were as sensitive as a p53-positive transformed reference cell line. p53-negative nontransformed cells induced apoptosis as eciently as p53-positive nontransformed cells. Therefore, neither the sensitivity of transformed cells to intercellular induction of apoptosis, nor the ability of nontransformed cells to induce apoptosis in transformed cells are dependent on p53. Intercellular induction of apoptosis in p53-negative transformed cells is not restricted to nontransformed C3H 10 T1/2 cells but seems to be a general feature of nontransformed cells (Table 2) . Dying p53-negative, as well as -positive transformed cells showed membrane blebbing, chromatin condensation and DNA strand breaks, as measured by the TUNEL reaction. Therefore, the cell death induced was apoptosis, as ensured by these hard and quanti®able criteria. Inhibition of apoptosis-induction by gamma-irradiation of the nontransformed cells ensured that the eects measured were truly due to intercellular induction of apoptosis. As recently shown, irradiation of nontransformed cells inhibits intercellular induction of apoptosis (Bassler et al., 1997) .
Our data show the existence of a p53-independent apoptotic pathway that is eciently used for intercellular induction of apoptosis in transformed cells. Further information on the biochemical mechanisms utilized in this pathway will be instrumental for the further understanding of the mechanisms acting during intercellular induction of apoptosis. Though our data demonstrate that p53 is not required for intercellular induction of apoptosis, they cannot exclude that p53-positive transformed cells utilize a p53-dependent mechanism for induction of apoptosis in parallel. However, as intercellular induction in p53-negative transformed cells is as fast and ecient as in p53-positive reference cells, the activity of the p53-negative pathway is sucient to explain the induction of Recent data reveal that intercellular induction of apoptosis depends on the action of reactive oxygen species in transformed cells, as it can be blocked with antioxidants and radical scavengers . The results presented here exclude a sequence of events where the action of ROS causes DNA damage and subsequent triggering of the classical p53 dependent apoptotic response.
As intercellular induction of apoptosis does not depend on functional p53, mutations of p53 during the process of carcinogenesis will not lead to an abrogation of this intercellular control system. Mutation of p53 will not render transformed cells resistant to intercellular induction of apoptosis nor will it abrogate the apoptosis-inducing potential of nontransformed cells.
Mechanisms leading to resistance against intercellular induction of apoptosis must therefore be searched in other genetic systems, papilloma viruses (Melchinger et al., 1996) and Bcl-2 (JuÈ rgensmeier and Bauer, 1997) already being valuable examples. As intercellular control is a fast acting and ecient process in vitro, activation of antiapoptotic mechanisms should occur before the transformation event in order to allow escape of transformed cells from induction of apoptosis. In line with this idea are the ®ndings that Bcl-2 activation precedes colon carcinogenesis (Bronner et al., 1995) and that papilloma virus infection is the prerequisite for the ecient action of mutagenic carcinogens (Gaukroger et al., 1993) . Bcl-2 has been shown in other systems to inhibit both p53-dependent (Chiou et al., 1994) and -independent apoptosis induction (Strasser et al., 1994; Subramanian et al., . Bcl-2 may therefore act at a central and common step of several apoptotic pathways. Degradation of p53 has been shown to occur in BPVtransformed cells (Band et al., 1993) . Obviously, this activity cannot explain the protective role of BPV for transformed cells in our system of intercellular induction of apoptosis, as p53 seems to be irrelevant for this activity. BPV therefore must interact with a so far unde®ned step during intercellular induction of apoptosis, which awaits further experimental analysis.
Materials and methods

Cell lines
Nontransformed mouse C3H 10 T1/2 C18 ®broblasts were obtained from U Rapp, University of WuÈ rzburg. The cells do not form colonies in soft agar and exhibit a very low rate of spontaneous transformation. Nontransformed 208F rat ®broblasts were obtained from R SchaÈ fer. ChariteÂ , Berlin. Their apoptosis-inducing potential has been recently described (Beck et al., 1997) . Nontransformed, nonimmortalized human Alpha-1 ®broblasts have been recently described (JuÈ rgensmeier et al., 1994) .
Methylcholanthrene (MCA)-transformed C3H 10 T1/2 cells (termed MCA 18 C115) were obtained as follows. C3H 10 T1/2 cells were treated with 5 mg/ml MCA for 24 h. Foci arizing after 2 weeks were isolated and the transformed cells were further subcloned in soft agar. The cells stably express the transformed phenotype, characterized by crisscross morphology, colony formation in soft agar and sensitivity to intercellular induction of apoptosis (Panse et al., 1997) .
Nontransformed ®broblasts from a p53 7/7 mouse were a generous gift of Dr G Brandner, University of Freiburg. They had been established from a newborn p53 7/7 mouse obtained from Bomholtgard Breeding and Research Center Ltd, Ry, Denmark. Transformed p53-negative cell lines were established by subcloning of a spontaneously arizing focus in the parental p53-negative nontransformed cell population (passage number 5). The transformed p53-negative cell lines have been termed p53 0/1 ± 4. They stably express the transformed phenotype (criss-cross morphology in monolayer and colony formation in soft agar). Parallel to acquisition of the transformed state, these cells seem to have lost cellular senescence programs spontaneously, as they can be passaged continuously. Nontransformed p53 null/null ®broblasts were used in passages 5 ± 8.
Cell culture Cells were kept in Eagle's Minimal Essential Medium, containing 5% fetal calf serum that had been heated for 30 min at 568C prior to use. Medium was supplemented with penicillin (40 U/ml), streptomycin (50 mg/ml), neomycin (10 mg/ml), moronal (10 U/ml) and glutamine (280 mg/ml). Cell culture was performed in plastic tissue culture¯asks. Cells were passaged once or twice weekly.
Transforming growth factor type b1 (TGF-b 1 ) TGF-b 1 was puri®ed from human platelets. The starting material was a generous gift of Dr C-H Heldin, Ludwig Institute for Cancer Research, Uppsala. A platelet extract was passed through CM-Sephadex to allow binding of PDGF. The¯ow through material was then allowed to bind to QAE-Sephadex and eluted under high salt conditions. High molecular weight (inactive) TGF-b 1 (HMW TGF-b) was further puri®ed by subsequent chromatography on DEAE-agarose and molecular sieve chromatography on BioGel A5. TGF-b 1 activity was monitored using its ability to induce Epstein-Barr virus antigen synthesis in latently infected cells, as previously described (Bauer et al., 1982) . Active, low molecular weight TGF-b 1 (further referred to as TGF-b) was obtained after molecular sieve chromatography on BioGel P150 in the presence of 0.1% sodium lauryl sulphate. Both its EpsteinBarr virus-inducing activity and reversible colony forming activity together with EGF were completely inhibited by neutralizing antibody (RD systems incorp., Minneapolis, USA) against TGF-b 1 .
Test for induction of apoptosis in transformed cells by TGF-beta 1-treated nontransformed cells 80 ± 100 clones of transformed cells were grown in Costar 6 well tissue culture clusters in MEM containing 5% FCS and 20% conditioned medium. After the clones had reached a size of about 50 cells per clone, they were labeled by scratching the tissue culture cluster from underneath with a needle and 6610 4 nontransformed cells were added. After these were attached, TGF-beta 1 was added at the indicated concentration. Nontransformed cells preferentially attach in the space between the transformed cell clones. Due to labeling of transformed clones prior to addition of nontransformed cells and due to the characteristic dierences in morphology (Wehrle et al., 1994) , transformed cell clones can be speci®cally monitored. After 4 ± 5 days of coculture, clones of transformed cells were scored for characteristics of apoptosis (membrane blebbing and chromatin condensation) as previously described . Three categories of clones were de®ned: category I: less than 10% of cells per clone showing morphological signs of apoptosis; category II: more than 10% and less than 50% of cells per clone showing morphological signs of apoptosis; category III: more than 50% of cells per clone showing morphological signs of apoptosis. As recently described , clonal analysis of transformed cells has the advantage to allow sensitive monitoring of ongoing intercellular induction of apoptosis. Apoptosis in the most sensitive clones can be measured independently of still ongoing survival and proliferation in less sensitive clones.
Bis-benzimidine staining of chromatin for the determination of apoptosis: Cells were rinsed with PBS and incubated with 1 mg/ml Bis-benzimidine (Hoechst 33258¯uorochrome) (0.9 mM acetic acid, 1 mM potassium acetate in methanol) for 30 min. After washing with aqua bidest, cells were embedded in McIlvane/glycerol (McIlvane's citrate-phosphate buer: 50 mM potassium dihydrogenphosphate, 50 mM citric acid, pH 5.5 mixed with an equal volume of glycerol). Cells were examined with a¯uorescence microscope, using excitation at 395 ± 440 nm.
In some experiments, apoptosis was further assured by the in situ terminal deoxynucleotidyl transferase assay (TUNEL reaction), which detects DNA strand breaks characteristic for apoptotic cells (Gorcyca et al., 1993) . A commercially available detection kit (Boehringer, Mannheim, Germany), based on the incorporation of Fluorescein-labelled dUTP, was used. After the TUNEL reaction, assays were stained with bis-benzimidine. This double staining procedure allows to test for DNA strand breaks and chromatin condensation at the level of individual and identical cells.
